Jonathan Hand, MD
- Sr Physician, Southshore Region
- 1514 Jefferson Hwy, New Orleans, LA, 70121
For additional information or to make an appointment, click here.
Overview
Overview
- Dr. Jonathan Hand earned his medical degree from Louisiana State University School of Medicine, New Orleans, and completed his internship, residency, and infectious diseases fellowship at the Icahn School of Medicine at Mount Sinai in New York. He is currently an Assistant Professor of Medicine at The University of Queensland School of Medicine Ochsner Clinical School. Dr. Hand specializes in the treatment of infections in immunocompromised patients who anticipate or undergo solid organ or hematopoietic stem cell transplantation as well as patients treated with other immunosuppressive therapies. He is a member of the American Society of Transplantation and has served on the executive committee of the Infectious Diseases community of practice. He is also a member of The Transplantation Society, International Society for Heart and Lung Transplantation, and the Infectious Diseases Society of America. Dr. Hand is the Medical Director of the Antimicrobial Stewardship Program and the Transplant Infectious Diseases Program at Ochsner Medical Center. He also serves as the Associate Medical Director of the Louisiana Organ Procurement Agency and co-chair of their advisory board. His practice and research interests include infectious complications of transplant recipients and antimicrobial stewardship.
Publications
Selected publications
-
2023Clinical features, treatment, and outcomes of mpox in solid organ transplant recipients: A multicenter case series and literature review. American Journal of Transplantation. 23:1972-1979.
-
2023
-
2023Infections After Kidney Transplantation from Donors with Hiv to Recipients with Hiv: Results from the Multicenter Hope in Action Study. American Journal of Transplantation. 23:S514-S514.
-
2023Safety and Efficacy of Kidney Transplantation from Donors with HIV to Recipients with HIV: Results of the Multicenter Hope in Action Study. American Journal of Transplantation. 23:S414-S414.
-
2023Wait Time Advantage for Transplant Candidates with HIV Who Accept Kidneys from Donors with HIV. American Journal of Transplantation. 23:S571-S572.
-
2022Antimicrobial stewardship in solid organ transplantation-A call for action!. Transplant Infectious Disease. 24.
-
2022
-
2021White paper on antimicrobial stewardship in solid organ transplant recipients. American Journal of Transplantation.
-
2021The time is now: antimicrobial stewardship in solid organ transplantation. Current Opinion in Organ Transplantation. 26:405-411.
-
2021Influence of Induction Therapy and Antiretroviral Regimen on Outcomes in HIV Positive Renal Transplant Recipients. American Journal of Transplantation. 21:369-369.
-
2021Liver Transplantation Using Hepatitis C Virus-Viremic Donors Into Hepatitis C Virus-Aviremic Recipients as Standard of Care. Liver Transplantation. 27:548-557.
-
2020Clarifying the HOPE Act landscape: The challenge of donors with false-positive HIV results. American Journal of Transplantation. 20:617-619.
-
2020Increased utilization of liver donors with infectious labels after implementation of a focused education program. American Journal of Transplantation. 20:38-39.
-
2019#Less Is More: Now Trending for Surgical Antibacterial Prophylaxis in Liver Transplantation. Liver Transplantation. 25:993-994.
-
2019Antimicrobial stewardship in transplant patients. Current Opinion in Organ Transplantation. 24:497-503.
-
2019Comment on: Do medical students feel prepared to prescribe antibiotics responsibly? Results from a cross-sectional survey in 29 European countries. Journal of Antimicrobial Chemotherapy. 74:276-277.
-
2019Perceptions and Attitude of Transplant Clinicians towards Antimicrobial Resistance and Stewardship in Transplant Recipients: A Survey of the American Society Transplantation.. American Journal of Transplantation. 19:737-737.
-
2019Reduction in Waitlist Time Using HCV Positive Liver Grafts in HCV Negative Recipients.. American Journal of Transplantation. 19:461-462.
-
2019Use of HCV Positive Livers in HCV Negative Recipients: The Ochsner Experience. American Journal of Transplantation. 19:70-70.
-
2018Challenges in Procalcitonin Implementation in the Real-World. OPEN FORUM INFECTIOUS DISEASES. 5.
-
2018Strategies for Antimicrobial Stewardship in Solid Organ Transplant Recipients. Infectious Disease Clinics of North America. 32:535.
-
2016Multidrug-resistant organisms in liver transplant: Mitigating risk and managing infections. Liver Transplantation. 22:1143-1153.